BACKGROUND & AIMS: The aim of this study was to assess factors associated with healthcare utilization in patients with chronic liver disease with a focus on pain, opioid use and psychiatric symptoms. METHODS: We retrospectively assessed a consecutive sample of 1286 visitors to a hepatology clinic with chronic liver disease. Baseline psychiatric symptoms, pain and opioid prescriptions were collected. Liver-related clinic visits, total clinic visits, phone calls and hospitalizations were assessed over a subsequent 6-month period. Multivariable logistic and negative binomial regression models were used to determine the medical and psychosocial factors associated with increased healthcare utilization. RESULTS: Over a 6-month period, hospitalization was more common among patients with pain (13% vs. 7%, P < 0.0001) and opioid usage (18% vs. 6% P < 0.0001). Pain and opioid usage were independently and significantly associated with an increased hospitalizations and median number of clinic visits and phone calls (P < 0.0001). In multivariable modelling, hospitalization was significantly associated with opioid use (OR = 2.72, CI = 1.72, 4.29), Child's Class B (OR = 2.24, CI = 1.19, 4.14) and C (OR = 8.51, CI = 4.18, 17.27) cirrhosis, and cardiopulmonary disease (OR = 2.11, CI = 1.28, 3.41). Pain and opioid usage were independently and significantly associated with the numbers of phone calls and total outpatient visits, as were medical comorbidities and Child's Class. The significant predictors of increased outpatient liver-related visits were pain (IRR = 1.13, CI = 1.02, 1.26), interferon usage (IRR = 1.75, CI = 1.54, 1.98) and more advanced liver disease (IRR = 1.58, CI = 1.32, 1.88). CONCLUSIONS: Pain and prescription opioid usage were significantly linked to increased healthcare utilization, suggesting the need to evaluate and incorporate evidence-based pain management strategies into routine care of patients with chronic liver disease.
BACKGROUND & AIMS: The aim of this study was to assess factors associated with healthcare utilization in patients with chronic liver disease with a focus on pain, opioid use and psychiatric symptoms. METHODS: We retrospectively assessed a consecutive sample of 1286 visitors to a hepatology clinic with chronic liver disease. Baseline psychiatric symptoms, pain and opioid prescriptions were collected. Liver-related clinic visits, total clinic visits, phone calls and hospitalizations were assessed over a subsequent 6-month period. Multivariable logistic and negative binomial regression models were used to determine the medical and psychosocial factors associated with increased healthcare utilization. RESULTS: Over a 6-month period, hospitalization was more common among patients with pain (13% vs. 7%, P < 0.0001) and opioid usage (18% vs. 6% P < 0.0001). Pain and opioid usage were independently and significantly associated with an increased hospitalizations and median number of clinic visits and phone calls (P < 0.0001). In multivariable modelling, hospitalization was significantly associated with opioid use (OR = 2.72, CI = 1.72, 4.29), Child's Class B (OR = 2.24, CI = 1.19, 4.14) and C (OR = 8.51, CI = 4.18, 17.27) cirrhosis, and cardiopulmonary disease (OR = 2.11, CI = 1.28, 3.41). Pain and opioid usage were independently and significantly associated with the numbers of phone calls and total outpatient visits, as were medical comorbidities and Child's Class. The significant predictors of increased outpatient liver-related visits were pain (IRR = 1.13, CI = 1.02, 1.26), interferon usage (IRR = 1.75, CI = 1.54, 1.98) and more advanced liver disease (IRR = 1.58, CI = 1.32, 1.88). CONCLUSIONS:Pain and prescription opioid usage were significantly linked to increased healthcare utilization, suggesting the need to evaluate and incorporate evidence-based pain management strategies into routine care of patients with chronic liver disease.
Authors: Jonathan M Fenkel; Roger N Coron; Constantine Daskalakis; Maricruz Vega; Simona Rossi; Steven K Herrine; Victor J Navarro Journal: Scand J Gastroenterol Date: 2010-09 Impact factor: 2.423
Authors: G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati Journal: Gastroenterology Date: 2001-01 Impact factor: 22.682
Authors: G Gudmundsson; T Gislason; C Janson; E Lindberg; R Hallin; C S Ulrik; E Brøndum; M M Nieminen; T Aine; P Bakke Journal: Eur Respir J Date: 2005-09 Impact factor: 16.671
Authors: Masako Hosoi; Ivan R Molton; Mark P Jensen; Dawn M Ehde; Silvia Amtmann; Sarah O'Brien; Tatsuyuki Arimura; Chiharu Kubo Journal: Pain Date: 2010-03-05 Impact factor: 7.926
Authors: Puneeta Tandon; Navdeep Tangri; Lesley Thomas; Laura Zenith; Tahira Shaikh; Michelle Carbonneau; Mang Ma; Robert J Bailey; Saumya Jayakumar; Kelly W Burak; Juan G Abraldes; Amanda Brisebois; Thomas Ferguson; Sumit R Majumdar Journal: Am J Gastroenterol Date: 2016-08-02 Impact factor: 10.864
Authors: Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Francis E Lotrich; Susan Zickmund; Eva Szigethy; Andrea F DiMartini Journal: Clin Gastroenterol Hepatol Date: 2014-11-05 Impact factor: 11.382
Authors: Shari S Rogal; Matthew J Chinman; William DeMonte; Sandra Gibson; Stephanie Hoyt-Trapp; Gloria J Klima; Naudia L Jonassaint; Jane M Liebschutz; Kevin L Kraemer; Jessica Merlin Journal: Dig Dis Sci Date: 2022-02-11 Impact factor: 3.487
Authors: Shari S Rogal; Lauren A Beste; Ada Youk; Michael J Fine; Bryan Ketterer; Hongwei Zhang; Steven Leipertz; Maggie Chartier; Chester B Good; Kevin L Kraemer; Matthew Chinman; Timothy Morgan; Walid F Gellad Journal: Clin Gastroenterol Hepatol Date: 2018-10-17 Impact factor: 11.382